Pulmonary Drugs Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 05
SKU : PH14
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Request new version
FAQ’s
What is the Pulmonary Drugs Market growth?
The market is growing at a CAGR of 4.8%.
Who are the key players in Pulmonary Drugs Market?
Major players are AstraZeneca, F. Hoffmann-La Roche Ltd, GlaxoSmithKline, Grifols, Merck & Co., Pfizer and Regeneron Pharmaceuticals.
Related Reports
pharmaceuticalsPulmonary Arterial Hypertension Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 February 26
Starting from
$4350
pharmaceuticalsPulmonary Edema Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 February 23
Starting from
$4350
pharmaceuticals-pa
Pulmonary Embolism – Pipeline Insight – 2018 Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2024 April 23
Starting from
$4350
pharmaceuticalsGenitourinary Drugs Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 September 27
Starting from
$4350
pharmaceuticalsOphthalmology Drugs and Devices Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 February 22
Starting from
$4350
pharmaceuticalsEpilepsy Drugs Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 09
Starting from
$4350